Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Accumulated Expenses (2017 - 2022)

AdaptHealth has reported Accumulated Expenses over the past 6 years, most recently at $50.5 million for Q3 2022.

  • For Q3 2022, Accumulated Expenses rose 24.84% year-over-year to $50.5 million; the TTM value through Sep 2022 reached $50.5 million, up 24.84%, while the annual FY2021 figure was $34.4 million, 28.7% up from the prior year.
  • Accumulated Expenses for Q3 2022 was $50.5 million at AdaptHealth, up from $28.9 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $50.5 million in Q3 2022 and troughed at $20609.0 in Q2 2018.
  • A 5-year average of $20.4 million and a median of $17.6 million in 2020 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: soared 17630.44% in 2018 and later tumbled 32.66% in 2022.
  • Year by year, Accumulated Expenses stood at $9.1 million in 2018, then skyrocketed by 34.76% to $12.3 million in 2019, then skyrocketed by 116.76% to $26.7 million in 2020, then rose by 28.7% to $34.4 million in 2021, then skyrocketed by 47.04% to $50.5 million in 2022.
  • Business Quant data shows Accumulated Expenses for AHCO at $50.5 million in Q3 2022, $28.9 million in Q2 2022, and $38.9 million in Q1 2022.